397 related articles for article (PubMed ID: 34362650)
21. Tri-modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell-free DNA using machine learning algorithm.
Bu J; Lee TH; Poellmann MJ; Rawding PA; Jeong WJ; Hong RS; Hyun SH; Eun HS; Hong S
Clin Transl Med; 2021 Aug; 11(8):e499. PubMed ID: 34459134
[No Abstract] [Full Text] [Related]
22. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsy: possibilities and limitations in uro-oncology.
López-Guerrero JA; Pastor-Navarro B; Claramunt-Alonso R; García-Flores M; Rubio-Briones J
Arch Esp Urol; 2022 Mar; 75(2):203-214. PubMed ID: 35332890
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
[TBL] [Abstract][Full Text] [Related]
25. Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Pantel K; Alix-Panabières C
Nat Rev Clin Oncol; 2019 Jul; 16(7):409-424. PubMed ID: 30796368
[TBL] [Abstract][Full Text] [Related]
26. Current and future perspectives of liquid biopsies in genomics-driven oncology.
Heitzer E; Haque IS; Roberts CES; Speicher MR
Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
[TBL] [Abstract][Full Text] [Related]
27. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
Guibert N; Pradines A; Favre G; Mazieres J
Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051167
[TBL] [Abstract][Full Text] [Related]
28. Potential clinical utility of liquid biopsies in ovarian cancer.
Zhu JW; Charkhchi P; Akbari MR
Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
[TBL] [Abstract][Full Text] [Related]
29. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
30. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
Heestermans R; Schots R; De Becker A; Van Riet I
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
[TBL] [Abstract][Full Text] [Related]
31. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
33. The Role of Liquid Biopsies in Pediatric Brain Tumors.
Tang K; Gardner S; Snuderl M
J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
[TBL] [Abstract][Full Text] [Related]
34. Exosome-based liquid biopsies in cancer: opportunities and challenges.
Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
[TBL] [Abstract][Full Text] [Related]
35. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer.
Balla A; Bhak J; Biró O
Mol Cell Probes; 2022 Dec; 66():101871. PubMed ID: 36283501
[TBL] [Abstract][Full Text] [Related]
36. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
37. Role of liquid biopsies in colorectal cancer.
Wills B; Gorse E; Lee V
Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
[TBL] [Abstract][Full Text] [Related]
38. The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.
Igari F; Tanaka H; Giuliano AE
Crit Rev Oncol Hematol; 2022 Jul; 175():103725. PubMed ID: 35618229
[TBL] [Abstract][Full Text] [Related]
39. Cell-free DNA in cancer: current insights.
Fettke H; Kwan EM; Azad AA
Cell Oncol (Dordr); 2019 Feb; 42(1):13-28. PubMed ID: 30367445
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy: blood-based analyses of circulating cell-free DNA in xenografts.
Heidrich I; Pantel K
EMBO Mol Med; 2022 Aug; 14(8):e16326. PubMed ID: 35903952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]